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 ADVANCING age is associated with increased risk of cardiovascular disease and a progressive decrease in 
cardiac function ( 1 ). Recent investigation using the Fischer 
344xBrown Norway F1 hybrid (F344XBN) rat model has 
demonstrated similar changes as aging in these animals is 
associated with an increased incidence of cardiac arrhyth-
mias as well as impairment of systolic and diastolic func-
tion ( 2 , 3 ). In addition, other data have shown that the aged 
F344XBN heart exhibits increased expression of oxidative –
 nitrosative stress markers ( 4 ). Reactive oxygen species 
(ROS) such as superoxide anions ( x 2O  ) and hydroxy radi-
cals ( • OH) have been implicated in cardiac dysfunction, re-
modeling, and in cardiomyocyte apoptosis ( 5 ). Whether 
aging in the F344XBN heart is associated with changes in 
cardiac apoptosis is not well understood. 
 The dystrophin – glycoprotein complex (DGC) is located 
within the cell membrane and provides a strong mechanical 
link between the cell cytoskeleton and the extracellular ma-
trix ( 6 ). In cardiac muscle, disruption of DGC may be 
involved in mediating contractile dysfunction, the develop-
ment of arrhythmias, and the progression of cardiac hyper-
trophy ( 7 – 14 ). How the cardiac DGC may be affected by 
aging and whether changes in the DGC may be related to 
increases in cardiac apoptosis have not been elucidated. 
Known components of the DGC include dystrophin, dys-
troglycans, sarcoglycans, integrins, caveolin-3, and others. 
The regulation of these proteins differs depending on mus-
cle type ( 15 ) and is altered, at least in skeletal muscle, with 
aging ( 16 ). Here, we hypothesized that aged F344XBN 
hearts exhibited age-related changes in cardiac function 
and morphology ( 3 , 4 ) and  would also exhibit increases in 
cardiac apoptosis and that this fi nding would be associated 
with alterations in the expression and localization of DGC 
proteins. Although incapable of proving cause and effect, 
the data of the present study suggest that alterations to the 
cardiac DGC may be implicated in the pathogenesis of age-
related cardiac dysfunction. 
 M aterials and M ethods 
 Animals 
 Animal care and procedures were conducted in accordance 
with the Animal Use Review Board of Marshall University 
using the criteria outlined by the American Association of 
Laboratory Animal Care (AALAC) as proclaimed in the An-
imal Welfare Act (PL89-544, PL91-979, and PL94-279). The 
animals and tissues used in this study have been previously 
examined ( 3 , 4 ). Adult (6 months,  n = 8), aged (30 months, 
 n = 8), and very aged (36 months,  n = 8) male F344XBN rats 
were obtained from the National Institute on Aging. Rats 
were housed two per cage in an AALAC -approved vivarium. 
Housing conditions consisted of a 12 hour:12 hour dark – light 
cycle with temperature maintained at 22  ± 2°C. Animals 
were provided food and water ad libitum. Rats were allowed 
to acclimate to the housing facilities for at least 2 weeks be-
fore experimentation began. During this time, the animals 
were carefully observed and weighed weekly. None of the 
animals exhibited signs of failure to thrive, such as precipi-
tous weight loss, disinterest in the environment, or unex-
pected gait alterations. 
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 Materials 
 Antibodies used were dystrophin (dys-2) from Novacas-
tro (Ontario, Canada);  a -dystroglycan (sc-28534),  b -
dystroglycan (sc16165),  b -sarcoglycan (Sc-28279), and 
 d -sarcoglycan (Sc-28281) were from Santa Cruz (Santa 
Cruz, CA);  a -sarcoglycan (VP-A105) from Vector Labora-
tories (Burlingame, CA); rat albumin (ab53435) from 
Abcam; and rat IgG antibody (T6392) from Molecular 
Probes (Eugene, OR). Caspase 3 (9662), caspase 9 (9506), 
 a -fodrin (2122), Akt (9272), Thr 308 phosphorylated Akt 
(9275), anti-rabbit (7074) and anti-mouse (7076) IgG sec-
ondary antibodies were purchased from Cell Signaling 
Technology (Beverly, MA). The In Situ Cell Death Detec-
tion Kit, Fluorescein (TdT-mediated dUTP nick end label-
ing [TUNEL]) was from Roche Diagnostics (Mannheim, 
Germany). Precast 10% sodium dodecyl sulfate – polyacryl-
amide gel electrophoresis (SDS-PAGE) gels were procured 
from Cambrex Biosciences (Baltimore, MD), and enhanced 
chemiluminescence (ECL) Western blotting detection re-
agent was from Amersham Biosciences (Piscataway, NJ). 
Restore Western blot stripping buffer was obtained from 
Pierce (Rockford, IL); 3T3 and L6 cell lysates were from 
Santa Cruz Biotechnology (Santa Cruz, CA). All other 
chemicals were purchased from Sigma (St. Louis, MO). 
 Cardiac Morphology 
 Animals were anesthetized with an intraperitoneal injec-
tion of ketamine (40 mg/kg) and xylazine (10 mg/kg), sup-
plemented as necessary for refl exive response. Hearts were 
quickly removed, blotted dry, weighed, and immediately fro-
zen in liquid nitrogen before storing at  − 80°C until use. His-
tological imaging and immunohistochemistry were performed 
on hearts sectioned (8  m m) using an IEC Minotome cryostat 
and collected on polylysine-coated slides (Sigma). Sections 
were stained with mallory phosphotungstic acid hematoxylin 
(PTAH) staining as outlined by the manufacturer (Poly Sci-
entifi c R & D Corp ., Bay Shore, NY) for the evaluation of 
cardiac morphology. Immunostaining for dystrophin, rat 
IgG, and albumin was performed as outlined by the antibody 
manufacturer. Briefl y, sections were incubated for 30 min-
utes in a blocking solution (5% bovine serum albumin [BSA] 
and phosphate-buffered saline [PBS] containing 0.5% Tween 
20 (PBS-T), pH 7.5) and then incubated with specifi c anti-
sera diluted in PBS-T (anti-dystrophin 1:100, rat-IgG 1:100) 
for 1 hour at 37°C in a humidifi ed chamber. After washing in 
PBS-T (3 × 5 minutes), sections were incubated with the ap-
propriate FITC or Texas RED labeled secondary antibody 
(1:200), if appropriate, for 1 hour at 37°C in a humidifi ed 
chamber. After mounting, specimens were visualized by epi-
fl uorescence using an Olympus fl uorescence microscope 
(Melville, NY) fi tted with a ×40 objective or on a Nikon Dia-
phot microscope (Bio-Rad, Hercules, CA) for confocal anal-
ysis. To allow approximate qualitative comparisons, all 
imaging parameters were kept constant between samples. 
 TUNEL Staining 
 DNA fragmentation after staining for dystrophin was deter-
mined by TUNEL according to the manufacturer ’ s recom-
mendations. TUNEL staining was performed on tissue sections 
(8  m m) obtained from 6-month ( n = 3), 30-month ( n = 3), and 
36-month ( n = 3) hearts, which were fi xed with 4% paraform-
aldehyde, washed with PBS (pH 7.4), and then permeabilized 
with 0.1% sodium citrate and 0.1% Triton-X. Additional 
experiments performed in parallel using DNase I or the omis-
sion of labeling reagent were used as positive and negative 
controls. Three randomly selected regions from each cross 
section were visualized by epifl uorescence using an Olympus 
fl uorescence microscope fi tted with a ×20 objective. Images 
were recorded digitally using a CCD camera (Olympus). 
 Protein Isolation and Immunoblotting 
 For the preparation of protein isolates, heart tissues were 
pulverized in liquid nitrogen using a mortar and pestle and 
washed three times with ice-cold PBS. Cytoplasmic proteins 
were extracted under mild conditions by incubating samples 
on ice in 2  m l/mg of T-PER (Pierce) protein extraction reagent 
that had been supplemented with (1.50 mM MgCl 2 , 1 mM 
EDTA, 1  m g/mL aprotinin, 1  m g/mL leupeptin, 1  m g/mL pep-
statin, 1 mM phenylmethanesulphonylfl uoride (PMSF) , 1 
mM Na 3 VO 4 ) for 5 minutes. After centrifugation (10 minutes 
at 800 g ), the supernant was removed and the pellets were re-
extracted twice. Membrane proteins were obtained by resus-
pending the pellet from the previous cytoplasmic extraction 
from the pulverized heart tissues (1 mL/g) in a buffer contain-
ing 1% deoxycholate, 1% NP-40, 10 mM NaPO 4 , 140 mM 
NaCl, and 2 mM EDTA supplemented with 100 mM NaF, 1 
mM Na 3 VO 4 , 2 mM PMSF, 1  m g/mL aprotinin, 1  m g/mL leu-
peptin, and 1  m g/mL pepstatin. After collecting the superna-
tant by centrifugation for 10 minutes at 800 g , protein 
concentration was determined in triplicate via the Bradford 
method (Pierce) using BSA as a standard. Samples were ana-
lyzed using 10% SDS-PAGE. To allow direct comparisons 
between age groups, 30  m g of samples from different age 
groups were loaded into consecutive wells of the same gel and 
ran. Following electrophoresis, proteins were transferred onto 
Hybond nitrocellulose membranes (Amersham Biosciences) 
using standard conditions ( 17 ). Membranes were stained with 
Ponceau S, and the amount of protein quantifi ed by densito-
metric analysis to confi rm successful transfer of proteins and 
equal loading of lanes as described previously ( 18 – 20 ). Mem-
branes were blocked in tris-buffered saline (TBS) with 0.5% 
Tween 20 (TBS-T) and 5% milk for 1 hour at room tempera-
ture, washed (TBS-T, 3 × 5 minutes), and incubated in pri-
mary antibody overnight at 4°C or 1 hour at room temperature 
as outlined by the antibody manufacturer. Immunoreactive 
protein bands were visualized by ECL Western blotting detec-
tion reagent. Film exposure time was adjusted to keep the 
integrated optical densities (IODs) within a linear and non-
saturated range, and band intensity was quantifi ed by 
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densitometry using a fl atbed scanner (Epson Perfection 3200 
PHOTO scanner, Epson America Inc., Long Beach, CA) and 
imaging software (AlphaEaseFC, Alpha Innotech, San Le-
andro, CA). Immunoblots were stripped with Restore West-
ern blot stripping buffer as outlined previously ( 21 ). 
 Statistical Analysis 
 Results are presented as mean  ±  SEM . Data were analyzed 
by using SigmaStat 3.0 (Systat Software Inc., Point Richmond, 
CA) computer software . One-way analysis of variance ( 22 ) 
was used for overall comparisons, with the Student-Newman-
Keuls post hoc test used to determine statistical signifi cance. 
The level of signifi cance accepted a priori was  p  ≤ .05 . 
 R esults 
 As reported previously ( 3 , 4 ), the body weight, heart 
weight, and body weight to heart weight ratios of these ani-
mals were increased in 30- and 36-month compared with 
6-month animals ( p < .05). PTAH staining of 6-month hearts 
demonstrated distinct myocyte striations, whereas very 
aged hearts showed presence of connective tissue infi ltra-
tion and loss of myocytes ( Figure 1 ). 
 Aging in the F344XBN Heart is Associated With Increased 
TUNEL Positive Nuclei, Elevated Caspase-3 Activation, 
and Diminished Akt Phosphorylation 
 To investigate the possibility that aging was associated 
with an increase in cardiac apoptosis, we examined the 
number of nuclei staining positively for DNA fragmenta-
tion by TUNEL staining. Compared with 6-month hearts, 
the number of TUNEL positive nuclei appeared to be mark-
edly increased in 30- and 36-month hearts ( Figure 2 ). 
 A critical step in the execution of the apoptotic pro-
gram that elicits DNA fragmentation is cleavage of cas-
pase-3 into 19 and 17 kDa fragments ( 23 ). Caspases are 
  
 Figure 1.  Aging alters the morphology of cardiac tissue in the F344XBN 
heart. Cross sections of hearts obtained from adult (6-month) and very aged 
(36-month) rats after staining with phosphotungstic acid hematoxylin to visual-
ize cardiac morphology. Bar = 20  m m . 
  
 Figure 2.  Aging increases the number of apoptotic nuclei in cardiomyocytes. TdT-mediated dUTP nick end labeling [TUNEL]  staining along with immunostain-
ing for dystrophin (Texas Red) was used to investigate myocytes apoptosis in 6-, 30-, and 36-month hearts. Bar = 50  m m. 
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cysteine-dependent aspartate-specifi c proteases function-
ing as endonucleases integral in the fi nal execution of 
nuclei and cell death ( 23 , 24 ). With aging, the amount 
of full-length (inactive) caspase-3 was 39% higher ( p < 
.05) in 30-month hearts, whereas it was 10% lower in 36-
month hearts as compared with 6-month hearts ( Figure 3 ; 
 p < .05). Caspase-3 cleavage into 17 kDa fragments was 
markedly higher (139%,  p < .05) in the 36-month hearts 
compared with that observed in 6-month animals ( Figure 3 ). 
Similarly, the 19-kDa fragment of caspase-3 was also 
32% ( p < .05) and 192% ( p < .05) higher in the 30- and 
36-month hearts, respectively ( Figure 3 ). 
 To examine the upstream signaling events responsible for 
caspase-3 activation, we next investigated the regulation of 
the caspase-9. Caspase-9 is cleaved and activated via mito-
chondrial cytochrome c release ( 25 ). Full-length (inactive) 
caspase-9 content was 31% higher in 36-month hearts ( p < 
.05) compared with 6-month hearts ( Figure 4 ). The 40-kDa 
fragment of caspase-9 was higher (35%) in 36-month hearts 
( p < .05), with no signifi cant difference between 6- and 30-
month hearts ( Figure 4 ). 
 As a means of further verifying the activation of cas-
pase-3, we also examined the effects of aging on the cleav-
age of  a -fodrin.  a -Fodrin is a cytoskeletal protein which 
undergoes caspase-dependent proteolytic processing in 
many types of cell death ( 26 ) but has not, to our knowledge, 
been studied in aging cardiac muscle. Compared with 
6-month animals, the amount of  a -fodrin was 14% lower in 
30-month hearts ( Figure 4 ). The full-length 240-kDa  a -
fodrin protein can be cleaved at several sites within its se-
quence by activated calpains to yield an N-terminal fragment 
of 150 kDa or by caspases to yield a C-terminal 120 kDa 
product ( 27 , 28 ). Compared with hearts obtained from 
6-month animals, the amount of the caspase-dependent (120 
kDa) form of  a -fodrin cleavage was 24% lower ( p < .05) in 
30-month and 17% higher ( p < .05) in 36-month hearts 
( Figure 4 ). The calpain-dependent (150-kDa) fragment of 
 a -fodrin cleavage was undetectable. 
 The Akt/PKB is a serine/threonine protein kinase that 
functions as a critical regulator of cell survival and prolif-
eration through numerous antiapoptotic actions ( 29 ). Given 
our fi ndings of increased TUNEL positive nuclei, we hy-
pothesized that aging would be associated with reduced 
Akt expression. The content of Akt was 28% and 14% lower 
( p < .05) in 30- and 36-month hearts compared with 6-month 
hearts ( Figure 4 ). Furthermore, Akt phosphorylation (Thr 
308) was reduced by 24% and 26% ( p < .05) in the 30- and 
36-month hearts, respectively ( Figure 4 ). Taken together, 
these data suggest that aging in the F344XBN heart is as-
sociated with increased cardiomyocyte apoptosis. 
 Aging in the F344XBN Heart is Associated With 
Alterations in the Cardiac DGC and Cardiac Membrane 
Integrity 
 Immunoblots of protein isolates obtained from the cyto-
solic and membrane fraction of 6-, 30-, and 36-month hearts 
were examined for the relative abundance of dystrophin. 
Compared with 6-month animals, the amount of cytoplas-
mic dystrophin protein was 26% and 23% higher ( p < .05) in 
30- and 36-month hearts, respectively ( Figure 5A ). Relative 
to 30-month animals, the amount of dystrophin in the mem-
brane fraction was 44% less ( p < .05) in 36-month animals. 
To assess the subcellular distribution of dystrophin, tissue 
sections from hearts of differently aged animals were exam-
ined by immunohistochemistry. Antibodies directed against 
the COOH terminus of dystrophin showed uniform immu-
noreactivity located predominantly along the cell membrane 
in the 6-month heart ( Figure 5B ). In comparison, dystrophin 
immunoreactivity in 30- and 36-month heart fi bers appeared 
irregular with patches of intense fl uorescence. With aging, 
the dystrophin immunoreactivity often appeared to be dis-
continuous and was at times completely absent along the 
sarcolemma ( Figure 5B ). 
 Because alterations in the amount of dystrophin may in-
fl uence the composition of the DGC, we next examined 
whether aging may affect the regulation of dystroglycans 
and sarcoglycans. Compared with 6-month animals, immu-
noblot analysis showed that the amount of  a -dystroglycan 
was 44% and 74% higher in cytosol and 16% and 23% 
higher in membrane fraction of 30- and 36-month hearts, 
respectively ( p < .05) ( Figure 6A ), indicating that the 
amount of  a -dystroglycan being localized to sarcolemma 
  
 Figure 3.  Aging increases the cleavage of caspase-3. Protein isolates from 
cytosolic fraction of hearts excised from adult (6-month), aged (30-month), and 
very aged (36-month) rats were analyzed by immunoblotting for changes in 
caspase-3 and caspase-3 cleavage. Ponceau S staining of the nitrocellulose 
membrane along with densitometric analysis of protein present was done to 
verify equivalent protein loading between the lanes (data not shown). Asterisk 
indicates signifi cant difference from adult (6-month) value ( p < .05). Dagger 
indicates signifi cant difference from 30-month value ( p < .05).  n = 8 for all 
groups. 
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was diminished with aging. Compared with 6-month hearts, the 
amount of cytosolic  b -dystroglycan was 36% and 37% lower in 
30- and 36-month hearts, respectively ( p < .05;  Figure 6B ). 
In contrast, the amount of membrane  b -dystroglycan was 
unchanged and 58% higher ( p < .05 ) in 30- and 36-month 
hearts compared with that observed in 6-month old animals 
( Figure 6B ). Immunoblot analysis using an antibody to a 
glycosylated epitope showed that the cardiac muscle mem-
brane content of  a -sarcoglycan was slightly decreased by 
8.5% and 14%, respectively ( p < .05) in 30- and 36-month 
  
 Figure 4.  Aging alters the regulation of mitochondrial dependent apoptotic pathway signaling proteins. Protein isolates from cytosolic fraction of hearts excised 
from adult (6-month), aged (30-month), and very aged (36-month) rats were analyzed by immunoblotting for changes in caspase-9,  a -fodrin, Akt, and Akt phospho-
rylation (Thr308). Ponceau S staining of the nitrocellulose membrane along with densitometric analysis of protein present was done to verify equivalent protein 
loading between the lanes (data not shown).  n = 8 for all groups. 
  
 Figure 5.  Aging alters the regulation of dystrophin in the F344XBN heart.  A ). Protein isolates from cytoplasmic and membrane fractions of hearts obtained from 
adult (6-month), aged (30-month), and very aged (36-month) rats were analyzed by immunoblotting for changes in dystrophin protein content. Ponceau S staining of 
the nitrocellulose membrane along with densitometric analysis of protein present was done to verify equivalent protein loading between the lanes (data not shown). 
Asterisk indicates signifi cant difference from adult (6-month) value ( p < .05). Dagger indicates signifi cant difference from 30-month value ( p < .05).  n = 8 for all 
groups.  B ). Dystrophin immunofl uorescence in 6-, 30-, and 36-month hearts. Arrows indicate irregular and discontinuous immunoreactive signaling along the sarco-
lemma in the 30- and 36-month hearts. Bar = 50  m m. 
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 Figure 7.  a -,  b -, and  d -sarcoglycan protein levels are altered with aging. 
Protein isolates excised from adult (6-month), aged (30-month), and very aged 
(36-month) rats were analyzed by immunoblotting for  a -,  b -, and  d -sarcoglycan 
protein expression.  n = 8 for all groups. 
hearts compared with 6-month animals ( Figure 7 ). Similarly, 
membrane  b -sarcoglycan content was reduced by 12% and 
16% in 30- and 36-month hearts, respectively ( p < .05; 
 Figure 7 ). Likewise, compared with 6-month hearts, the 
amount of  d -sarcoglycan was reduced by 28% and 19% in 
30- and 36-month hearts, respectively, ( p < 0.05;  Figure 7 ). 
Together, these data suggest that aging in the F344XBN 
heart is associated with changes in the composition of the 
cardiac DGC. 
 Because DGC is known to play a pivotal role in stabilizing 
the muscle cell membrane and changes in cardiomyocyte 
membrane permeability are associated with cellular apopto-
sis ( 30 ), we next examined whether alterations in the DGC 
complex were associated with evidence of increased mem-
brane permeability. To test this possibility, tissue sections 
obtained from 6-, 30-, and 36-month rat hearts were exam-
ined for the presence of IgG (150 kDa), a serum protein, and 
albumin, a plasma constituent that is normally excluded from 
entry into the muscle fi ber. No evidence of IgG ( Figure 8A ) 
and albumin ( Figure 8B ) immunoreactivity was demon-
strated in the cytosol of cardiac muscle fi bers obtained from 
  
 Figure 6.  Aging alters the regulation of dystroglycans in the F344XBN heart. Protein isolates from cytoplasmic and membrane fractions of hearts excised from 
adult (6-month), aged (30-month), and very aged (36-month) rats were analyzed by immunoblotting for changes in ( A )  a -dystroglycan and ( B )  b -dystroglycan protein 
expression. Ponceau S staining of the nitrocellulose membrane along with densitometric analysis of protein present was done to verify equivalent protein loading 
between the lanes (data not shown). Asterisk indicates signifi cant difference from adult (6-month) value ( p < .05). Dagger indicates signifi cant difference from 30-
month muscles ( p < .05).  n = 8 for all groups. 
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6-month rats. In contrast, very aged rats exhibited positive 
staining with anti-rat IgG and anti-rat albumin antibodies in 
the cytoplasm of cardiac myofi bers obtained from 36-month 
rats ( Figure 8A and B ). This fi nding consistent with the 
notion that aging in the F344XBN heart is associated with 
increased cardiomyocyte permeability. 
 D iscussion 
 In the present investigation, we examined how aging 
may affect cardiomyocyte apoptosis in the hearts of ani-
mals that have previously been shown by echocardiography 
to exhibit age-related dysfunction and biochemically to ex-
hibit increased oxidative – nitrosative stress ( 3 , 4 ). Here, we 
demonstrate that aging in the F344XBN rat heart is associ-
ated with changes in cardiac morphology and an increase in 
the number of TUNEL positive cells ( Figures 1 and  2 ). 
These data, considered in concert with our previous fi nd-
ings, suggest that aging-associated increases in oxidative –
 nitrosative stress may be related to cardiomyocyte loss. 
 In order to investigate potential mechanisms of the apop-
tosis observed in our TUNEL studies, we determined how 
aging affected the expression and activation of two key effec-
tors of mitochondrial-mediated apoptosis, caspase-3 and -9 
( 31 – 33 ). With advanced aging, we observed increases in the 
amount of cleaved caspase-3 and its upstream activator, 
caspase-9 ( Figures 3 and  4 ). Supporting the possibility that 
caspase-3 activation occurs with aging, we also observed that 
the amount of caspase-cleaved  a -fodrin content was in-
creased with advanced aging ( Figure 4 ). Taken together, 
these data support the notion that the mitochondrial apoptotic 
cascade may contribute to apoptosis in the aging F344XBN 
heart. This is in agreement with the results of other recent 
investigations that have implicated mitochondrial-mediated 
apoptosis in the loss of cardiomyocytes with aging ( 34 , 35 ). 
In addition to increased proapoptotic caspase activity, we 
also demonstrate that age-related increases in the cardiac 
apoptosis in the F344XBN are associated with decreased 
phosphorylation of Akt ( Figure 4 ). Why Akt phosphorylation 
may be decreased with aging is currently unclear. 
 Alterations to the muscle DGC and how these changes 
may infl uence muscle morphology or function have been 
well examined in the muscular dystrophies ( 36 , 37 ). Duch-
enne and Becker muscular dystrophies are associated with 
a high incidence of dilated cardiomyopathy ( 7 , 38 ), and 
dystrophin mutations are a cause of X-linked dilated 
cardiomyopathy ( 12 , 39 ). These observations suggest that 
structural and functional impairments of DGC may serve 
to promote cardiac dysfunction ( 40 ). Thus, we hypothe-
sized that age-related disruptions of cardiac DGC func-
tion may be partially responsible for the degenerative role 
of normative aging on heart function. One of the main 
fi ndings of the present study is that aging in the F344XBN 
rat heart is associated with alterations in the expression 
levels of dystrophin ( Figure 5 ), dystroglycans ( Figure 6 ), 
and sarcoglycans ( Figure 7 ). Interestingly, the regulation 
of these proteins appears to occur in a diametric fashion. 
For example, although the amount of  a -,  b -dystroglycan 
protein levels increases in the membrane fraction with 
aging, the amount of dystrophin and the  a -,  b -, and  d -
sarcoglycans decrease. It has been hypothesized that  b -dys-
troglycan acts as a link between proteins in the DGC 
complex and the extracellular matrix ( 41 ). Thus, it is tempt-
ing to speculate that the age-associated upregulation of 
  
 Figure 8.  Aging is associated with a loss of cardiac myocyte membrane integrity.  A ). Double immunofl uorescence labeling with dystrophin (FITC) and rat IgG 
(Texas Red) in 6-, 30-, and 36-month hearts. Increased permeability of the myocytes membrane is indicated by intracellular IgG reactivity. Note diffuse immunoreac-
tive signaling within the cytoplasm of the 30- and 36-month hearts.  B ). Immunofl uorescent labeling with anti-rat albumin in 6-, 30-, and 36-month hearts. Note local-
ization of albumin in 30- and 36-month hearts. Bar = 50  m m. 
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the dystroglycans that we show may represent an attempt 
by the cardiomyocyte to  “ re-establish ” a functional con-
nection between the cell cytoskeleton and the extracellular 
matrix. Although not examined here, it is interesting to note 
that previous work has demonstrated that inhibition of 
 a -dystroglycan binding to laminin-2 is associated with 
diminished Akt phosphorylation and the induction of apop-
tosis in muscle cell cultures ( 42 ). Whether the decreased 
phosphorylation of Akt we observe in the aging F344XBN 
heart is due to alterations in the interaction between  a -
dystroglycan and laminin-2 or some other mechanism will 
require further investigation. 
 Although the exact function of DGC is not fully under-
stood, it is known to regulate the structural stability of the 
muscle cell membrane. Indeed, alterations in dystrogly-
can or sarcoglycan levels have been shown to cause mus-
cle membrane instability ( 43 , 44 ), and cardiomyocytes 
lacking dystrophin are abnormally vulnerable to mechan-
ical stress – induced injury causing loss of sarcolemmal 
integrity and myofi brillar degeneration that can lead to 
contractile dysfunction ( 6 , 45 ). Our fi ndings of increased 
intracellular cytoplasmic IgG and albumin immunoreac-
tivity in the aged F344XBN hearts ( Figure 8 ) are consis-
tent with this notion. This destabilization of the membrane, 
in turn, has been linked to increased cellular apoptosis 
( 42 , 46 ), which is in agreement with our fi nding of in-
creased cardiomyocyte apoptosis with aging. Whether 
changes in the DGC precede elevations in cardiac ROS 
and apoptosis or if alterations in cardiac ROS and apopto-
sis occur prior to modifi cation of the DGC is not known 
and, unfortunately, cannot be determined from the present 
data. Future studies using cultured cardiomyocytes and 
siRNAs to alter expression of different DGC proteins may 
be useful in increasing our understanding of the cause and 
effect relationship between cardiomyocyte apoptosis and 
age-related changes in DGC. 
 In summary, this study demonstrates that aging in the 
F344XBN rats is characterized by increased cardiomyo-
cyte apoptosis and alterations in the expression and local-
ization of cardiac DGC proteins. Although not capable of 
proving cause and effect, these data when considered in 
conjunction with our previous reports are consistent with 
the possibility that age-associated increases in cardiac 
dysfunction, oxidative – nitrosative stress, and apoptotic 
activity in the F344XBN aging model may be due, at least 
in part, to age-related changes in DGC structure and func-
tion ( Figure 9 ) ( 3 , 4 ). Further experiments using other 
time points within the aging spectrum and other types of 
analysis will no doubt be useful in determining if this 
venue is worth exploring. 
 Funding 
 This study was supported by  National Institutes of Health Grant No. 
 AG-027103 to E.R.B. 
 Correspondence 
 Address correspondence to Eric R. Blough, PhD, Laboratory of Molecu-
lar Physiology, Suite 311, Room 241N, Robert C. Byrd Biotechnology Sci-
ence Center, Department of Biological Sciences, 1700 3rd Avenue, Marshall 
University, Huntington, WV 25755-1090. Email:  blough@marshall.edu 
 References 
  1.  Lakatta  EG .  Aging and cardiovascular structure and function in 
healthy sedentary humans .  Aging (Milano) .  1998 ; 10 : 162 – 164 . 
  2.  Hacker  TA ,  McKiernan  SH ,  Douglas  PS ,  Wanagat  J ,  Aiken  JM .  Age-
related changes in cardiac structure and function in Fischer 344 x 
Brown Norway hybrid rats .  Am J Physiol Heart Circ Physiol .  2006 ; 
 290 : H304 – H311 . 
  3.  Walker  EM ,  Jr. ,  Nillas  MS ,  Mangiarua  EI  et al .  Age-associated 
changes in hearts of male Fischer 344/Brown Norway F1 rats .  Ann 
Clin Lab Sci .  2006 ; 36 : 427 – 438 . 
  4.  Asano  S ,  Rice  KM ,  Kakarla  S  et al .  Aging infl uences multiple indices 
of oxidative stress in the heart of the Fischer 344/NNia x Brown Nor-
way/BiNia rat .  Redox Rep .  2007 ; 12 : 167 – 180 . 
  5.  Tsutsui  H ,  Ide  T ,  Kinugawa  S .  Mitochondrial oxidative stress, DNA 
damage, and heart failure .  Antioxid Redox Signal .  2006 ; 8 : 1737 – 1744 . 
  6.  Lapidos  KA ,  Kakkar  R ,  McNally  EM .  The dystrophin glycoprotein 
complex: signaling strength and integrity for the sarcolemma .  Circ 
Res .  2004 ; 94 : 1023 – 1031 . 
  7.  Beggs  AH .  Dystrophinopathy, the expanding phenotype. Dystrophin 
abnormalities in X-linked dilated cardiomyopathy .  Circulation . 
 1997 ; 95 : 2344 – 2347 . 
  8.  Frank  JS ,  Mottino  G ,  Chen  F ,  Peri  V ,  Holland  P ,  Tuana  BS .  Subcellular 
distribution of dystrophin in isolated adult and neonatal cardiac myo-
cytes .  Am J Physiol .  1994 ; 267 : C1707 – C1716 . 
  9.  Hein  S ,  Kostin  S ,  Heling  A ,  Maeno  Y ,  Schaper  J .  The role of the cy-
toskeleton in heart failure .  Cardiovasc Res .  2000 ; 45 : 273 – 278 . 
 10.  Keller  RS ,  Shai  SY ,  Babbitt  CJ  et al .  Disruption of integrin function in 
the murine myocardium leads to perinatal lethality, fi brosis, and ab-
normal cardiac performance .  Am J Pathol .  2001 ; 158 : 1079 – 1090 . 
 11.  Kostin  S ,  Hein  S ,  Arnon  E ,  Scholz  D ,  Schaper  J .  The cytoskeleton and 
related proteins in the human failing heart .  Heart Fail Rev .  2000 ; 5 :
 271 – 280 . 
  
 Figure 9.  Proposed model for how changes in the dystrophin – glycoprotein 
complex (DGC) may be related to age-related cardiac dysfunction. Data from 
the literature support the existence of increased oxidative stress and contractile 
dysfunction in aged cardiac muscle. Changes in the cardiac DGC could contrib-
ute to each of these processes either directly or by causing changes in cell per-
meability or by increasing myocyte apoptosis. Dashed arrows indicate cellular 
mechanisms that have been postulated to participate where as solid arrows indi-
cate measures that were experimentally assessed in this study. 
  AGING HEART AND THE DYSTROPHIN COMPLEX 155
 12.  Ortiz-Lopez  R ,  Li  H ,  Su  J ,  Goytia  V ,  Towbin  JA .  Evidence for a dys-
trophin missense mutation as a cause of X-linked dilated cardiomyo-
pathy .  Circulation .  1997 ; 95 : 2434 – 2440 . 
 13.  Petrof  BJ ,  Shrager  JB ,  Stedman  HH ,  Kelly  AM ,  Sweeney  HL .  Dystro-
phin protects the sarcolemma from stresses developed during muscle 
contraction .  Proc Natl Acad Sci U S A .  1993 ; 90 : 3710 – 3714 . 
 14.  Wang  J ,  Hoshijima  M ,  Lam  J  et al .  Cardiomyopathy associated with 
microcirculation dysfunction in laminin alpha4 chain-defi cient mice .  J 
Biol Chem .  2006 ; 281 : 213 – 220 . 
 15.  Wheeler  MT ,  Allikian  MJ ,  Heydemann  A ,  McNally  EM .  The sarco-
glycan complex in striated and vascular smooth muscle .  Cold Spring 
Harb Symp Quant Biol .  2002 ; 67 : 389 – 397 . 
 16.  Rice  KM ,  Preston  DL ,  Neff  D ,  Norton  M ,  Blough  ER .  Age-related 
dystrophin-glycoprotein complex structure and function in the rat ex-
tensor digitorum longus and soleus muscle .  J Gerontol A Biol Sci Med 
Sci .  2006 ; 61 : 1119 – 1129 . 
 17.  Towbin  H ,  Staehelin  T ,  Gordon  J .  Electrophoretic transfer of proteins 
from polyacrylamide gels to nitrocellulose sheets: procedure and some 
applications. 1979 .  Biotechnology .  1992 ; 24 : 145 – 149 . 
 18.  Gupte  AA ,  Bomhoff  GL ,  Geiger  PC .  Age-related differences in skel-
etal muscle insulin signaling: the role of stress kinases and heat shock 
proteins .  J Appl Physiol .  2008 ; 105 : 839 – 848 . 
 19.  Marzetti  E ,  Wohlgemuth  SE ,  Lees  HA ,  Chung  HY ,  Giovannini  S , 
 Leeuwenburgh  C .  Age-related activation of mitochondrial caspase-
independent apoptotic signaling in rat gastrocnemius muscle .  Mech 
Ageing Dev .  2008 ; 129 : 542 – 549 . 
 20.  Wheeler  MT ,  Zarnegar  S ,  McNally  EM .  Zeta-sarcoglycan, a novel 
component of the sarcoglycan complex, is reduced in muscular dys-
trophy .  Hum Mol Genet .  2002 ; 11 : 2147 – 2154 . 
 21.  Costelli  P ,  Reffo  P ,  Penna  F ,  Autelli  R ,  Bonelli  G ,  Baccino  FM .  Ca(2+)-
dependent proteolysis in muscle wasting .  Int J Biochem Cell Biol . 
 2005 ; 37 : 2134 – 2146 . 
 22.  Chen  WS ,  Xu  PZ ,  Gottlob  K  et al .  Growth retardation and increased 
apoptosis in mice with homozygous disruption of the Akt1 gene . 
 Genes Dev .  2001 ; 15 : 2203 – 2208 . 
 23.  Zhang  Y ,  Herman  B .  Ageing and apoptosis .  Mech Ageing Dev . 
 2002 ; 123 : 245 – 260 . 
 24.  Hengartner  MO .  The biochemistry of apoptosis .  Nature .  2000 ; 407 : 
 770 – 776 . 
 25.  Saraste  A ,  Pulkki  K .  Morphologic and biochemical hallmarks of apop-
tosis .  Cardiovasc Res .  2000 ; 45 : 528 – 537 . 
 26.  Martin  SJ ,  O’Brien  GA ,  Nishioka  WK  et al .  Proteolysis of fodrin 
(non-erythroid spectrin) during apoptosis .  J Biol Chem .  1995 ; 270 : 
 6425 – 6428 . 
 27.  Janicke  RU ,  Ng  P ,  Sprengart  ML ,  Porter  AG .  Caspase-3 is required for 
alpha-fodrin cleavage but dispensable for cleavage of other death sub-
strates in apoptosis .  J Biol Chem .  1998 ; 273 : 15540 – 15545 . 
 28.  Vanags  DM ,  Porn-Ares  MI ,  Coppola  S ,  Burgess  DH ,  Orrenius  S .  Pro-
tease involvement in fodrin cleavage and phosphatidylserine exposure 
in apoptosis .  J Biol Chem .  1996 ; 271 : 31075 – 31085 . 
 29.  Song  G ,  Ouyang  G ,  Bao  S .  The activation of Akt/PKB signaling path-
way and cell survival .  J Cell Mol Med .  2005 ; 9 : 59 – 71 . 
 30.  Green  AM ,  Steinmetz  ND .  Monitoring apoptosis in real time .  Cancer 
J .  2002 ; 8 : 82 – 92 . 
 31.  Cai  J ,  Yang  J ,  Jones  DP .  Mitochondrial control of apoptosis: the role of 
cytochrome c .  Biochim Biophys Acta .  1998 ; 1366 : 139 – 149 . 
 32.  Goldspink  DF ,  Burniston  JG ,  Tan  LB .  Cardiomyocyte death and the 
ageing and failing heart .  Exp Physiol .  2003 ; 88 : 447 – 458 . 
 33.  Porter  AG ,  Janicke  RU .  Emerging roles of caspase-3 in apoptosis .  Cell 
Death Differ .  1999 ; 6 : 99 – 104 . 
 34.  Kwak  HB ,  Song  W ,  Lawler  JM .  Exercise training attenuates age-
induced elevation in Bax/Bcl-2 ratio, apoptosis, and remodeling in the 
rat heart .  FASEB J .  2006 ; 20 : 791 – 793 . 
 35.  Phaneuf  S ,  Leeuwenburgh  C .  Cytochrome c release from mitochon-
dria in the aging heart: a possible mechanism for apoptosis with 
age .  Am J Physiol Regul Integr Comp Physiol .  2002 ; 282 : R423 –
 R430 . 
 36.  Brown  RH ,  Jr.  Dystrophin-associated proteins and the muscular dys-
trophies .  Annu Rev Med .  1997 ; 48 : 457 – 466 . 
 37.  Kirschner  J ,  Bonnemann  CG .  The congenital and limb-girdle muscu-
lar dystrophies: sharpening the focus, blurring the boundaries .  Arch 
Neurol .  2004 ; 61 : 189 – 199 . 
 38.  Malhotra  SB ,  Hart  KA ,  Klamut  HJ  et al .  Frame-shift deletions in pa-
tients with Duchenne and Becker muscular dystrophy .  Science . 
 1988 ; 242 : 755 – 759 . 
 39.  Muntoni  F ,  Cau  M ,  Ganau  A  et al .  Brief report: deletion of the dystro-
phin muscle-promoter region associated with X-linked dilated cardio-
myopathy .  N Engl J Med .  1993 ; 329 : 921 – 925 . 
 40.  Towbin  JA ,  Bowles  KR ,  Bowles  NE .  Etiologies of cardiomyopathy 
and heart failure .  Nat Med .  1999 ; 5 : 266 – 267 . 
 41.  Ervasti  JM ,  Campbell  KP .  A role for the dystrophin-glycoprotein com-
plex as a transmembrane linker between laminin and actin .  J Cell Biol . 
 1993 ; 122 : 809 – 823 . 
 42.  Langenbach  KJ ,  Rando  TA .  Inhibition of dystroglycan binding to 
laminin disrupts the PI3K/AKT pathway and survival signaling in 
muscle cells .  Muscle Nerve .  2002 ; 26 : 644 – 653 . 
 43.  Cote  PD ,  Moukhles  H ,  Carbonetto  S .  Dystroglycan is not required 
for localization of dystrophin, syntrophin, and neuronal nitric-
oxide synthase at the sarcolemma but regulates integrin alpha 7B 
expression and caveolin-3 distribution .  J Biol Chem .  2002 ; 277 :
 4672 – 4679 . 
 44.  Sampaolesi  M ,  Yoshida  T ,  Iwata  Y ,  Hanada  H ,  Shigekawa  M .  Stretch-
induced cell damage in sarcoglycan-defi cient myotubes .  Pfl ugers 
Arch .  2001 ; 442 : 161 – 170 . 
 45.  Danialou  G ,  Comtois  AS ,  Dudley  R  et al .  Dystrophin-defi cient cardio-
myocytes are abnormally vulnerable to mechanical stress-induced 
contractile failure and injury .  FASEB J .  2001 ; 15 : 1655 – 1657 . 
 46.  Rando  TA .  Role of nitric oxide in the pathogenesis of muscular dystro-
phies: a  “ two hit ” hypothesis of the cause of muscle necrosis .  Microsc 
Res Tech .  2001 ; 55 : 223 – 235 . 
 Received  June  24 ,  2009 
 Accepted  December  3 ,  2009 
 Decision Editor: Huber R. Warner, MD, PhD 
